Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 7/20 | 0.63 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.63 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.63 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL402173 | 0.90 | ALDH1A1 (0.59) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL402501 | 0.86 | MAPT (0.57) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL14453250 | 0.85 | ALDH1A1 (0.59) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL13218896 | 0.85 | ALDH1A1 (0.59) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL77143 | 0.83 | PRKCA (0.75) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL5026886 | 0.83 | PRKCA (0.60) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL2927505 | 0.83 | PRKCA (0.75) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL16580778 | 0.82 | ALDH1A1 (0.51) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL2197625 | 0.80 | PRKCA (0.87) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL29862879 | 0.80 | PRKCA (0.87) | PRKCAPRKCEPRKCQPRKCDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8906961-B2 | Glycerol levulinate ketals and their use in the manufacture of polyurethanes, and polyurethanes formed therefrom | SEGETIS, INC. (US) | 2014-12-09 | — | — | US | disclosed |
| US-20130303648-A1 | GLYCEROL LEVULINATE KETALS AND THEIR USE IN THE MANUFACTURE OF POLYURETHANES, AND POLYURETHANES FORMED THEREFROM | GFBIOCHEMICALS LIMITED (MT) | 2013-11-14 | — | — | US | disclosed |
| US-8492433-B2 | Glycerol levulinate ketals and their use in the manufacture of polyurethanes, and polyurethanes formed therefrom | SEGETIS, INC. (US) | 2013-07-23 | — | — | US | disclosed |
| EP-1954140-B1 | GLYCEROL LEVULINATE KETALS AND THEIR USE | SEGETIS INC (US) | 2013-05-29 | — | — | EP | disclosed |
| US-20120196947-A1 | GLYCEROL LEVULINATE KETALS AND THEIR USE IN THE MANUFACTURE OF POLYURETHANES, AND POLYURETHANES FORMED THEREFROM | SEGETIS, INC. (US) | 2012-08-02 | — | — | US | disclosed |
| US-8178701-B2 | Glycerol levulinate ketals and their use | SEGETIS, INC. (US) | 2012-05-15 | — | — | US | disclosed |
| US-20120021962-A1 | GLYCEROL LEVULINATE KETALS AND THEIR USE | SEGETIS, INC. (US) | 2012-01-26 | — | — | US | disclosed |
| US-8053468-B2 | Glycerol levulinate ketals and their use | SEGETIS, INC. (US) | 2011-11-08 | — | — | US | disclosed |
| US-20080242721-A1 | plasticizers; polylactones and polyurethanes prepared from them; substituted oxymethylene moiety attached to the dioxolane ring is predominantly in the cis configuration relative to the configuration of the side chain bearing the carboxyl group | AROMAGEN CORPORATION (US) | 2008-10-02 | — | — | US | disclosed |
| EP-1954140-A2 | GLYCEROL LEVULINATE KETALS AND THEIR USE | Aromagen Corporation (US) | 2008-08-13 | — | — | EP | disclosed |
| WO-2007062118-A2 | GLYCEROL LEVULINATE KETALS AND THEIR USE | AROMAGEN CORPORATION (US) | 2007-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242721-A1 | plasticizers; polylactones and polyurethanes prepared from them; substituted oxymethylene moiety attached to the dioxolane ring is predominantly in the cis configuration relative to the configuration of the side chain bearing the carboxyl group | GK, FTO, DGKK | PRKCA 62/4885PRKCE 124/4885PRKCQ 396/4885 |
| US-20120021962-A1 | GLYCEROL LEVULINATE KETALS AND THEIR USE | GK, GRIK5, KHK | PRKCA 351/4885PRKCE 280/4885PRKCQ 690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.